Related Experiment Video

Updated: Jun 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Natural history of chronic hepatitis C: genotype 1 versus genotype 6

Wai-Kay Seto1, Ching-Lung Lai, James Fung

  • 1Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

Journal of Hepatology
|June 18, 2010
PubMed

Insights

Chronic hepatitis C virus (HCV) genotype 1 and 6 share similar disease progression and outcomes. Genotype 1 patients were mostly infected via blood transfusion, while genotype 6 patients were more commonly infected through injection drug use.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Limited data exists on the natural history of chronic hepatitis C virus (HCV) genotype 6.
  • Understanding genotype-specific differences is crucial for managing HCV infection.

Purpose of the Study:

  • To compare the natural history of chronic hepatitis C virus (HCV) genotype 1 and genotype 6 infections.
  • To analyze differences in transmission routes, liver biochemistry, viral load, and clinical outcomes.

Main Methods:

  • A comparative study of 138 HCV genotype 1 patients and 78 HCV genotype 6 patients.
  • Baseline data including demographics, transmission route, liver function tests, and HCV RNA levels were collected.
  • Rates of complications and mortality were analyzed over time.

Main Results:

  • HCV genotype 1 patients were predominantly infected via blood transfusion (71.7%), versus 56.4% for genotype 6 (p<0.05).
  • Intravenous drug addiction was a more common transmission route for genotype 6 (28.2%) compared to genotype 1 (8.7%) (p<0.05).
  • No significant differences were observed in liver biochemistry, HCV RNA levels, development of cirrhotic complications, hepatocellular carcinoma, or mortality between the two groups.

Conclusions:

  • HCV genotype 1 and 6 infections exhibit comparable liver biochemistry, viral load, and long-term clinical outcomes.
  • Transmission routes differ significantly, with blood transfusion more common for genotype 1 and injection drug use for genotype 6.
  • These findings highlight the need for genotype-specific prevention strategies and underscore similar disease progression.
Abstract

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...